Besides, HCP5 and PSMB8-AS1 have been demonstrated could be the tumor-infiltrating immune-related lncRNA signature of non-small cell lung cancer and closely associated with outcome and immune cell infiltrates (Sun et al., 2020). The gene discussed is HCP5; the disease is non-small cell lung carcinoma.